Question 1

What is the catalog number for PE human CD13 Antibody?

Accepted Answer

The catalog number for PE human CD13 Antibody is orb3066030.

Question 2

What sizes are available for PE human CD13 Antibody?

Accepted Answer

PE human CD13 Antibody is available in the following size(s): 25 Tests, 100 Tests.

Question 3

How many pack sizes does PE human CD13 Antibody come in?

Accepted Answer

PE human CD13 Antibody is available in 2 different pack sizes.

Question 4

Is PE human CD13 Antibody in stock?

Accepted Answer

PE human CD13 Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is PE human CD13 Antibody used for?

Accepted Answer

PE human CD13 Antibody

Question 6

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

Question 7

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 8

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

PE human CD13 Antibody

Product Specifications

Reactivity

Conjugation

Field of Research

Storage Conditions

Notes

Tested Applications

Host or Source

Available Sizes

Frequently Asked Questions

Explore Other Products

ZRANB2 Mouse Monoclonal Antibody [Clone ID: OTI2E3]

2-Cyclohexylvinylboronic Acid

C-Myc (9E10.3), CF488A conjugate, 0.1mg/mL

Hyperoside

4-Ethylbenzophenone

ZDHHC14 Human Gene Knockout Kit (CRISPR)